Skip to main content

delta Opioid R/OPRD1 Antibody - BSA Free

Novus Biologicals, part of Bio-Techne | Catalog # NLS222

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NLS222

Key Product Details

Species Reactivity

Validated:

Human

Predicted:

Monkey (94%), Primate (100%). Backed by our 100% Guarantee.

Applications

Immunohistochemistry, Immunohistochemistry-Paraffin

Label

Unconjugated

Antibody Source

Polyclonal Rabbit IgG

Format

BSA Free

Concentration

1.0 mg/ml

Product Specifications

Immunogen

Synthetic 17 amino acid peptide from N-terminal extracellular domain of human delta Opioid R/OPRD1.

Epitope

N-Terminus extracellular domain

Reactivity Notes

Predicted cross-reactivity based on sequence identity: Gorilla (100%), Marmoset (94%), Mouse (88%), Canine (88%), Bovine (88%), Equine (88%).

Localization

Multi pass membrane protein

Specificity

Human delta Opioid R/OPRD1. BLAST analysis of the peptide immunogen showed no homology with other human proteins.

Clonality

Polyclonal

Host

Rabbit

Isotype

IgG

Description

Product can be stored undiluted at 4C for up to 1 month.

Scientific Data Images for delta Opioid R/OPRD1 Antibody - BSA Free

Immunohistochemistry-Paraffin: delta Opioid R/OPRD1 Antibody - BSA Free [NLS222]

Immunohistochemistry-Paraffin: delta Opioid R/OPRD1 Antibody - BSA Free [NLS222]

Immunohistochemistry-Paraffin: delta Opioid R/OPRD1 Antibody [NLS222] - Brain, Glioblastoma
Immunohistochemistry-Paraffin: delta Opioid R/OPRD1 Antibody - BSA Free [NLS222]

Immunohistochemistry-Paraffin: delta Opioid R/OPRD1 Antibody - BSA Free [NLS222]

Immunohistochemistry-Paraffin: delta Opioid R/OPRD1 Antibody [NLS222] - Analysis of anti-Delta Opioid Receptor antibody with human brain, neurons and glia.
Immunohistochemistry-Paraffin: delta Opioid R/OPRD1 Antibody - BSA Free [NLS222]

Immunohistochemistry-Paraffin: delta Opioid R/OPRD1 Antibody - BSA Free [NLS222]

Immunohistochemistry-Paraffin: delta Opioid R/OPRD1 Antibody [NLS222] - Anti-OPRD1 / Delta Opioid Receptor antibody IHC of human Skin, Melanoma. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval.

Applications for delta Opioid R/OPRD1 Antibody - BSA Free

Application
Recommended Usage

Immunohistochemistry-Paraffin

4 - 38 ug/ml
Application Notes
.

Formulation, Preparation, and Storage

Purification

Immunogen affinity purified

Formulation

PBS

Format

BSA Free

Preservative

0.1% Sodium Azide

Concentration

1.0 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Keep as concentrated solution. Aliquot and store at -20C or below. Avoid multiple freeze-thaw cycles.

Background: delta Opioid R/OPRD1

OPRD1 is an Opioid Receptor that is involved in the control of anxiety, depression, and pain. It is a promising target in the therapy of mood-altering disorders and drug addiction. Delta and kappa opioid receptors function synergistically by forming heterodimers. OPRD1 expression has been reported primarily in the brain. High OPRD1 expression has been documented in the cortex, caudate, hippocampus, nucleus accumbens, and putamen; low OPRD1 expression has been identified in the cerebellum, hypothalamus, substantia nigra, and thalamus. OPRD1 expression is reduced in the putamen and amygdala of Alzheimer's patients and in the putamen in Parkinson's disease.

Long Name

delta Opioid Receptor

Alternate Names

DOP, dOpioidR, DOR1, OP1, OPRD1

Entrez Gene IDs

4985 (Human)

Gene Symbol

OPRD1

Additional delta Opioid R/OPRD1 Products

Product Documents for delta Opioid R/OPRD1 Antibody - BSA Free

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for delta Opioid R/OPRD1 Antibody - BSA Free

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...